Generic Rebetol meeting
Executive Summary
Three Rivers Pharmaceuticals meets with FDA Chief Counsel Daniel Troy to discuss "labeling issues" for generic version of Schering-Plough's Rebetol (ribavirin) June 24. Three Rivers expects 2003 launch for the generic...
You may also be interested in...
Generic Ribavirin Labels Will Carve Out Rebetol/PEG-Intron Indication
Three Rivers Pharmaceuticals is amending its ribavirin ANDA to remove references to an 800 mg dose appearing in Schering-Plough's Rebetol labeling
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.